Ence Chuck 4
4 · RELMADA THERAPEUTICS, INC. · Filed Jan 11, 2021
Insider Transaction Report
Form 4
Ence Chuck
CAO and COO
Transactions
- Award
Options to purchase common stock
2021-01-07+112,500→ 112,500 totalExercise: $33.43From: 2022-01-07Exp: 2031-01-07→ Common Stock (112,500 underlying) - Award
Options to purchase common stock
2021-01-07+112,500→ 112,500 totalExercise: $33.43From: 2021-04-07Exp: 2031-01-07→ Common Stock (112,500 underlying)
Footnotes (2)
- [F1]The options vest from the date of grant in equal quarterly increments of 6.25% over a four-year period.
- [F2]The options vest 25% one year from the date of grant, and thereafter in equal quarterly increments of 6.25% over the following three years. The options are subject to forfeiture upon failure by the Issuer to reach certain corporate objectives in 2021.